NLS Pharmaceutics AG (NLSP)
NASDAQ: NLSP · Real-Time Price · USD
2.420
+0.290 (13.62%)
At close: Aug 13, 2025, 4:00 PM
2.480
+0.060 (2.48%)
Pre-market: Aug 14, 2025, 9:08 AM EDT
NLS Pharmaceutics AG Market Cap
NLS Pharmaceutics AG has a market cap or net worth of $7.65 million as of August 14, 2025. Its market cap has decreased by -24.68% in one year.
Market Cap
7.65M
Enterprise Value
5.98M
1-Year Change
-24.68%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since the IPO on January 29, 2021, NLS Pharmaceutics AG's market cap has decreased from $20.11M to $7.65M, a decrease of -61.99%. That is a compound annual growth rate of -19.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 7.65M | 123.37% |
| Dec 31, 2024 | 3.42M | -82.11% |
| Dec 29, 2023 | 19.13M | -55.33% |
| Dec 30, 2022 | 42.83M | 161.62% |
| Dec 31, 2021 | 16.37M | -18.61% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |